Introduction {#Sec1}
============

Ultrasound technology is rapidly evolving to become smaller, more affordable, and more user-friendly. A new category of smaller handheld devices has recently emerged whose main advantages include increased portability and affordability. The incorporation of such a device into the initial physical examination could potentially lend to faster diagnosis and treatment. Early applications of portable ultrasound have been in the field of echocardiography, and some concern exists about whether image quality is being unsafely compromised to achieve greater portability \[[@CR1], [@CR2]\].

At least three such battery-powered devices are either on the market or soon to be released: the handheld unit we tested has recently been granted FDA approval for use on human subjects, and as such very little field testing has thus far taken place. The unit has a probe that can be held in one hand and is attached by a stethoscope-like cord to the main unit which is approximately 4″ × 6″; together they weigh \<2 lbs. The main unit houses the imaging screen, the battery, and the hardware and software. To achieve the smaller size, engineers removed the transducer motor and some of the probe's crystal components, resulting in more work for the operator to acquire static images (B-mode) or real-time imaging guidance (in M-mode).

We designed a prospective study to test a novice handheld device for the performance of ultrasound-guided paracenteses and thoracenteses.

Setting {#Sec2}
=======

Cedars-Sinai Medical Center is a 957 bed, tertiary care teaching facility located in Los Angeles, California. The Signos was evaluated by the Procedure Center, a unique operation responsible for the provision of myriad invasive medical procedures for inpatients and outpatients \[[@CR3]\].

Methods {#Sec3}
=======

A prospective, non-blinded study was designed to evaluate a Signos handheld ultrasound device for paracenteses and thoracenteses on human patients. There were no exclusion criteria. The study was performed by a single operator (advanced proceduralist) and divided into three phases: In phase one, the Signos was applied to all consecutive cases in a 2-week period. Each evaluation began with the patient being scanned and marked for needle entry using the Signos, and was then reevaluated (and remarked, as needed) using the Sonosite *M*-*Turbo*, which is our current "gold standard" ultrasound device used in the Procedure Center. The M-Turbo can be carried, but usually resides on a wheel-based portable stand. Each Signos scan was graded as *excellent* (high level of correlation with Sonosite), *adequate* (slightly less informative but enough to proceed), *marginal* (confirmation with Sonosite was useful and provided necessary information), or *poor* (inadequate to proceed without additional imaging). Lastly, each study was flagged if it needed to be "remarked" with the Sonosite prior to beginning.

In phase two, the Signos was again used by the same experienced proceduralist for the same procedures. Each case was evaluated and marked for needle entry with the Signos. In this phase, the Sonosite was only used *if needed* to confirm localization and/or remark. Each study was again graded: excellent (excellent image quality, no confirmation with Sonosite needed), adequate (slightly less informative but adequate to proceed), marginal (confirmation and additional information was obtained with the Sonosite), or poor (inadequate to proceed without additional confirmation/remarking). Cases were also marked as "solo" (without Sonosite) or "added" (Sonosite used).

Phase three was an educational phase using Signos and Sonosite, designed to evaluate the experience of novice trainees during a one-day training session; their experiences were captured by a brief questionnaire (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Signos evaluation survey

The Signos was on loan from Signostics for evaluation of its use, and the Sonosite M-Turbo is owned by the Procedure Center.

Results {#Sec4}
=======

The results of phases one and two are depicted in Table [1](#Tab1){ref-type="table"}, and comparative images are displayed in Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}. Phase three captured the experience of five novice trainees on four different parameters. The average responses were as follows: question 1 = 9.1/10, question 2 = 7.6/10, question 3 = 8.1/10, and question 4 = 8.9/10.Table 1Phase one and two resultsExcellentAdequateMarginalPoorRemarking requiredPhase one (89 cases) Thoracentesis (34 cases)27 (79%)4 (12%)3 9%)02 (6%) Paracentesis (33 cases)29 (79%)3 (9%)1 (3%)00 Evaluation only (22 cases)15 (68%)7 (32%)00n/aPhase two (85 cases) Thoracentesis (38 cases)38 (100%)00038 Solo (100%) Paracentesis (35 cases)29 (83%)6 (17%)0031 Solo (89%) Evaluation only (12 cases)12 (100%)000n/aFig. 2Thoracentesis comparative images.**a** Signos,**b** SonositeFig. 3Paracentesis comparative images. **a** Signos,**b** Sonosite

There were no major or minor complications from the procedures, and the Signos itself performed without technical difficulty. The portable battery life proved more than sufficient for an entire day of heavy use.

Discussion {#Sec5}
==========

Extreme portability is one of the most striking aspects of the Signos. The entire device can fit in the pocket of a white coat or be worn around the neck like a stethoscope, making it ideal for highly mobile practitioners such as proceduralists, hospitalists, intensivists, emergency physicians, outpatient practitioners, and home care clinicians. The ergonomic layout was highly functional, with the buttons and roller ball well-positioned to allow for right or left-handed single-handed operation.

The results indicated that the image quality proved overall to be adequate. The advanced proceduralist experienced a rapid learning curve for image acquisition and interpretation during phase one, and with practice the image quality became strikingly similar to images obtained with the Sonosite. After the brief learning curve, the Signos was sufficient for procedure completion without further imaging for the vast majority of straight-forward studies. However, for difficult cases with smaller fluid collections or anatomic aberrations, further localization with the Sonosite remained important in both phase one and two.

The novice practitioners in phase three had a generally positive response, although this phase was limited by a small "*n*" and too brief a test period for competency to be assessed \[[@CR4]\].

We recognize several limitations of this study. First, this represents the experience of a single, non-blinded operator who subjectively judged each image based on his experience. Further, he is considered to be a master proceduralist (having performed thousands of ultrasound-guided procedures), so the reproducibility of his learning curve and aptitude is uncertain relative to an average user's experience or learning curve with new ultrasound technology. Lastly, this study examined only one aspect of ultrasound as it related to procedure guidance for fluid removal; therefore, extrapolation to other ultrasound applications should be approached with caution.
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